EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel 2-(2′-Benzothiazolyl)-benzimidazole-Based Iridium(III) Photocatalysts Exhibit Antiproliferative Effects in 2D and 3D Cancer Cells to Bypass Hypoxia-Induced Resistance

Antonio Linero-Artiaga iD, Marie Svitelova, Vojtěch Novohradský iD, Venancio Rodríguez iD, Lenka Markova iD, Jana Kasparkova iD, Christoph Janiak, José Ruiz iD, Viktor Brabec iD

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.5c03280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Antonio Linero-Artiaga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Inorgánica, Universidad de Murcia, and Murcia BioHealth Research Institute (IMIB-Arrixaca), E-30100 Murcia, Spain. Hauptthemen laut MEDLINE: Iridium, Benzimidazoles, Antineoplastic Agents, Coordination Complexes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundaci?n S?neca, Ministerio de Ciencia, Innovaci?n y Universidades, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explores the therapeutic potential of seven bis-cyclometalated Ir(III) complexes (1-7), derived from the 2,2'-(benzothiazolyl)benzimidazole scaffold, as highly promising next-generation photoactivatable agents for type I and type II-guided photodynamic therapy (PDT) in lung and colorectal cancers. Their high phototoxicity in 2D and 3D cancer cell models, achieving IC50 values in the nanomolar region, was closely linked to the generation of singlet oxygen and type I reactive oxygen species (ROS) and the photooxidation of NADH, with complex 4 identified as the strongest ROS inducer and the most photocytotoxic complex. Notably, the iridium complexes proved to maintain their phototoxicity in hypoxic conditions. Using 3D spheroids, complex 4 demonstrated deep tissue penetration sought to overcome PDT limitations in solid tumors. Overall, the synthesized complexes showcase high efficacy and favorable pharmacological profiles, positioning them as promising candidates for the ROS-guided photodynamic treatment of cancers, including those located within hypoxic environments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IridiumBenzimidazolesAntineoplastic AgentsCoordination ComplexesPhotosensitizing AgentsBenzothiazolesHumansCell ProliferationPhotochemotherapyReactive Oxygen SpeciesCell Line, TumorCell HypoxiaAnimalsDrug Screening Assays, Antitumor

Substanzen

IridiumBenzimidazolesAntineoplastic AgentsCoordination ComplexesReactive Oxygen SpeciesPhotosensitizing AgentsBenzothiazoles

Autor:innen und Institutionen

  • Departamento de Química Inorgánica, Universidad de Murcia, and Murcia BioHealth Research Institute (IMIB-Arrixaca), E-30100 Murcia, Spain.
  • Czech Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61200 Brno, Czech Republic.
  • Department of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, Palackeho trida 1946/1, CZ-61200 Brno, Czech Republic.
  • Department of Biophysics, Faculty of Science, Palacky University, Slechtitelu 27, CZ-78371 Olomouc, Czech Republic.
  • Institut für Anorganische Chemie und Strukturchemie, Heinrich-Heine-Universität Düsseldorf, D-40204 Düsseldorf, Germany.

ORCID-Profile: Antonio Linero-Artiaga, Vojtěch Novohradský, Venancio Rodríguez, Lenka Markova, Jana Kasparkova, José Ruiz, Viktor Brabec

Förderung

  • Fundaci?n S?neca
  • Ministerio de Ciencia, Innovaci?n y Universidades
  • European Regional Development Fund
  • Grantov? Agentura Cesk? Republiky
  • Universidad de Murcia

Zitieren

APA

Linero-Artiaga, A., Svitelova, M., Novohradský, V., Rodríguez, V., Markova, L., Kasparkova, J., Janiak, C., Ruiz, J., & Brabec, V. (2026). Novel 2-(2′-Benzothiazolyl)-benzimidazole-Based Iridium(III) Photocatalysts Exhibit Antiproliferative Effects in 2D and 3D Cancer Cells to Bypass Hypoxia-Induced Resistance. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c03280

Vancouver

Linero-Artiaga A, Svitelova M, Novohradský V, Rodríguez V, Markova L, Kasparkova J, et al. Novel 2-(2′-Benzothiazolyl)-benzimidazole-Based Iridium(III) Photocatalysts Exhibit Antiproliferative Effects in 2D and 3D Cancer Cells to Bypass Hypoxia-Induced Resistance. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c03280

BibTeX
@article{LineroArtiaga2026,
  author = {Linero-Artiaga, Antonio and Svitelova, Marie and Novohradský, Vojtěch and Rodríguez, Venancio and Markova, Lenka and Kasparkova, Jana and Janiak, Christoph and Ruiz, José and Brabec, Viktor},
  title = {Novel 2-(2′-Benzothiazolyl)-benzimidazole-Based Iridium(III) Photocatalysts Exhibit Antiproliferative Effects in 2D and 3D Cancer Cells to Bypass Hypoxia-Induced Resistance},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.5c03280}
}
Kostenlos starten →